Clearer labels needed on drugs containing animal products

Patients with specific dietary restrictions may be unwittingly taking medicines containing animal products, suggests an article published in BMJ today.

Dr Kinesh Patel and Dr Kate Tatham say most medications prescribed in primary care contain animal derived products and it is unclear whether they are suitable for vegetarians.

They call for improved labelling, similar to those on food, to help inform doctors, pharmacists and patients about the content of medicines. And they stress that concerned patients should not stop taking their medication without consulting their doctor first.

Specific dietary preferences regarding animal products in food are common in the general population. Influences such as religion, culture, economic status, environmental concern, food intolerances, and personal preferences all play a part in the foods that people choose to consume.

Yet many patients and doctors are unaware that commonly prescribed drugs contain animal products – and simply reading the list of ingredients will not make it clear whether the product meets the patient's dietary preferences.

Problem ingredients include lactose (often extracted using bovine rennet), gelatine (sourced from cows, pigs and occasionally fish) and magnesium stearate (traditionally sourced from cows, pigs and sheep) although some manufacturers now use vegetarian alternatives.

Last year a campaign to vaccinate children in Scotland against influenza was halted because of concern in the Muslim community about pork gelatine within the vaccine.

Even though the absolute levels of animal products in many medications are likely to be minimal, the authors say doctors need to consider this when prescribing "to avoid non-adherence, which is a major healthcare concern."

To ascertain the scale of the problem, they identified the 100 most commonly prescribed drugs in UK in January 2013. Of these, 73 contained one or more of lactose, gelatine, or magnesium stearate. But they found that information on the origins of the contents was difficult to obtain, unclear, inconsistently reported, and sometimes incorrect.

"Our data suggest that it is likely that patients are unwittingly ingesting medications containing with neither prescriber nor dispenser aware," they write.

They call for improved drug labelling, mirroring those standards advised for food. However, they acknowledge it is unlikely that any labelling standard could address all dietary requirements, "and the ultimate solution would be to eliminate animal derived products where possible from medications."

They point out that lactose is already produced by some manufacturers without using rennet, magnesium stearate can be made chemically without animal ingredients and vegetarian capsules to replace gelatine are already available.

"Although vegetarian friendly ingredients may be more expensive than those produced by traditional processes, the costs would diminish as production expanded and they would limit the exposure of to products they find unacceptable," they conclude.

More information: www.bmj.com/cgi/doi/10.1136/bmj.g401

add to favorites email to friend print save as pdf

Related Stories

The alternative to yogurt

Jan 05, 2014

Researchers at the Universitat Politècnica de València have obtained new products fermented with probiotic bacteria from grains and nuts - what is known as plant-based or vegetable "milks" - which are an ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

1 hour ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.